Suppr超能文献

一种基于术前癌胚抗原与全身炎症反应联合检测的可切除胃癌新型预后标志物。

A novel prognosis marker based on combined preoperative carcinoembryonic antigen and systemic inflammatory response for resectable gastric cancer.

作者信息

Ma Yubin, Lin Junpeng, Lin Jianxian, Hou Junfang, Xiao Qin, Yu Fang, Ma Zhijun, Li Ping, Tu Ruhong, Xie Jianwei, Zheng Chaohui, Yan Su, Huang Changming

机构信息

Department of Gastrointestinal Oncology, Qinghai University Affiliated Hospital, Xining, People's Republic of China.

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.

出版信息

J Cancer. 2021 Jan 1;12(3):927-935. doi: 10.7150/jca.52299. eCollection 2021.

Abstract

Carcinoembryonic antigen (CEA) is one of the important indexes for the diagnosis and prognosis of gastrointestinal cancer. Systemic inflammatory response (SIR) is closely related to the occurrence and development of gastrointestinal cancer. A total of 803 patients who underwent radical gastrectomy in Qinghai University Affiliated Hospital from January 2012 to December 2016 were included as training set. Multivariable Cox proportional hazard regression was used to identify associations with outcome of gastric cancer (GC). CNLR was established by combining CEA and the neutrophils to lymphocytes ratio (NLR, a typical parameter in SIR) to generate a novel prognostic score system and its prognostic value was externally validated. Multivariate analysis showed that CEA and NLR were independent prognostic factors for GC patients (both < 0.05). A higher CNLR was significantly associated with older age, male sex, larger tumor size, vascular invasion and advanced stages (all < 0.05). Patients with higher CNLR had poor prognosis than those with lower CNLR ( < 0.05). Multivariate analysis showed that CNLR was an independent prognostic factor ( < 0.05). Incorporation of the CNLR into a prognostic model including age and TNM stage generated a nomogram, which predicted accurately 3- and 5-year survival for GC patients. And similar results were obtained in the external validation set. The CNLR prognostic scoring system established by combining CEA and NLR is an independent prognostic factor for GC, which can be incorporated into the traditional TNM staging to improve the prediction of long-term survival outcomes.

摘要

癌胚抗原(CEA)是胃肠道癌诊断和预后的重要指标之一。全身炎症反应(SIR)与胃肠道癌的发生发展密切相关。选取2012年1月至2016年12月在青海大学附属医院接受根治性胃切除术的803例患者作为训练集。采用多变量Cox比例风险回归分析来确定与胃癌(GC)预后的相关性。通过将CEA与中性粒细胞与淋巴细胞比值(NLR,SIR中的一个典型参数)相结合建立CNLR,以生成一种新的预后评分系统,并对其预后价值进行外部验证。多因素分析显示,CEA和NLR是GC患者的独立预后因素(均P<0.05)。较高的CNLR与老年、男性、肿瘤较大、血管侵犯及晚期显著相关(均P<0.05)。CNLR较高的患者预后比CNLR较低的患者差(P<0.05)。多因素分析显示,CNLR是一个独立的预后因素(P<0.05)。将CNLR纳入包括年龄和TNM分期的预后模型中生成了列线图,该列线图能准确预测GC患者3年和5年生存率。在外部验证集中也获得了类似结果。通过结合CEA和NLR建立的CNLR预后评分系统是GC的独立预后因素,可纳入传统TNM分期以改善对长期生存结局的预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcb/7778548/30b631b2b17f/jcav12p0927g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验